Picture of Yichang Hec Changjiang Pharmaceutical Co logo

1558 — Yichang Hec Changjiang Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Yichang Hec Changjiang Pharmaceutical Expects Q4 Revenue Of RMB1,780 Mln, Up 125%

Jan 2 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd  1558.HK :
    * EXPECTS THAT CO WILL RECORD A REVENUE OF ABOUT RMB1,780
MILLION
FOR 3 MONTHS FROM 1 OCT 2019 TO 31 DEC 2019
    * EXPECTED INCREASE IN REVENUE DUE TO CONTINUOUS INCREASE IN
SALES
REVENUE OF CO'S PRODUCT KEWEI

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS4PtJcC
Further company coverage:  1558.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Yichang Hec Changjiang Pharmaceutical Co

See all news